-
公开(公告)号:US11857634B2
公开(公告)日:2024-01-02
申请号:US17049152
申请日:2019-04-20
Inventor: Song Li , Jingjing Sun , Yichao Chen , Yixian Huang , Yanhua Liu , Binfeng Lu
IPC: A61K47/58 , A61K47/54 , A61K9/107 , A61K31/65 , C12N15/113
CPC classification number: A61K47/58 , A61K9/1075 , A61K31/65 , A61K47/549 , C12N15/113 , C12N2310/14 , C12N2310/351
Abstract: A formulation includes a plurality of polymers including a hydrophobic polymer backbone (for example, formed via radical polymerization), a first plurality of pendant groups attached to the hydrophobic polymer backbone and including at least one cationic group, and a second plurality of pendant groups attached to the hydrophobic polymer backbone and including at least one hydrophilic polymer, a first therapeutic compound, and a second therapeutic compound, wherein the second therapeutic compound is different from the first therapeutic compound and includes a nucleic acid.
-
公开(公告)号:US20210236645A1
公开(公告)日:2021-08-05
申请号:US17049152
申请日:2019-04-20
Inventor: Song Li , Jingjing Sun , Yichao Chen , Yixian Huang , Yanhua Liu , Binfeng Lu
IPC: A61K47/58 , A61K47/54 , C12N15/113 , A61K9/107 , A61K31/65
Abstract: A formulation includes a plurality of polymers including a hydrophobic polymer backbone (for example, formed via radical polymerization), a first plurality of pendant groups attached to the hydrophobic polymer backbone and including at least one cationic group, and a second plurality of pendant groups attached to the hydrophobic polymer backbone and including at least one hydrophilic polymer, a first therapeutic compound, and a second therapeutic compound, wherein the second therapeutic compound is different from the first therapeutic compound and includes a nucleic acid.
-
公开(公告)号:US20240131170A1
公开(公告)日:2024-04-25
申请号:US18540254
申请日:2023-12-14
Inventor: Song Li , Jingjing Sun , Yichao Chen , Yixian Huang , Yanhua Liu , Binfeng Lu
IPC: A61K47/58 , A61K9/107 , A61K31/65 , A61K47/54 , C12N15/113
CPC classification number: A61K47/58 , A61K9/1075 , A61K31/65 , A61K47/549 , C12N15/113 , C12N2310/14 , C12N2310/351
Abstract: A formulation includes a plurality of polymers including a hydrophobic polymer backbone (for example, formed via radical polymerization), a first plurality of pendant groups attached to the hydrophobic polymer backbone and including at least one cationic group, and a second plurality of pendant groups attached to the hydrophobic polymer backbone and including at least one hydrophilic polymer, a first therapeutic compound, and a second therapeutic compound, wherein the second therapeutic compound is different from the first therapeutic compound and includes a nucleic acid.
-
-